Related Experiment Video
Updated: Aug 6, 2026

A Novel In Vitro Live-imaging Assay of Astrocyte-mediated Phagocytosis Using pH Indicator-conjugated Synaptosomes
Published on: February 5, 2018
APP/Aβ Signaling Orchestrates Reactive Astrocyte Networks in Alzheimer's Disease
Gretsen Velezmoro Jauregui1, Sophie Coomes2, Elizabeth Emmett3
1International Translational Neuroscience Research Institute, Zhejiang Chinese Medical University, Hangzhou, Zhejiang, China.
Alzheimer's disease (AD) progression may be driven by astrocytes. Astrocytic amyloid precursor protein (APP) signaling integrates local stress, initiating amyloid-beta (Aβ) accumulation and neuroinflammation in early AD.
Area of Science:
- Neuroscience
- Cell Biology
- Pathology
Background:
- Alzheimer's disease (AD) involves amyloid-beta (Aβ) plaques, neurofibrillary tangles, synaptic loss, and neuroinflammation.
- The precise mechanisms initiating early, localized AD pathology are not fully understood.
- Astrocytes, crucial glial cells, express amyloid precursor protein (APP) and possess APP processing machinery.
Purpose of the Study:
- To investigate the role of astrocytic APP signaling in the early pathogenesis of Alzheimer's disease.
- To explore how local tissue stress influences astrocytic APP processing and contributes to AD pathology.
- To propose a novel framework for understanding AD initiation centered on astrocyte-neuron interactions.
Main Methods:
- Analysis of astrocytic APP expression and processing under various stress conditions.
- Investigating the impact of astrocytic APP fragments on astrocyte reactivity and function.
- Modeling the proposed feed-forward signaling loop involving astrocytic APP and Aβ.
Main Results:
- Astrocytes upregulate APP and shift to amyloidogenic processing in response to local tissue stress.
- Bioactive APP fragments, including Aβ, activate astrocytes and disrupt their homeostatic functions.
- This process creates a self-reinforcing cycle, promoting localized amyloid accumulation and neuroinflammation.
Conclusions:
- Astrocytic APP signaling acts as an upstream initiator of localized pathology in Alzheimer's disease.
- The proposed model highlights a reciprocal coupling between astrocytic APP and Aβ, driving disease progression.
- This astrocyte-centric view offers new therapeutic targets for preventing or slowing sporadic AD.
Related Concept Videos
Alzheimer Disease ll: Pathophysiology
Alzheimer's Disease: Overview
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
Alzheimer Disease l: Introduction
